evidence table

Bacopa Cognition Randomized Trial Evidence Table

Structured evidence table for Bacopa Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Bacopa Cognition Randomized TrialDiscussion This trial will provide evidence on BMFD's potential to preserve telomere length, support cognitive functions, and slow aging processes.2Pradeep HLNR (2026)Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
Bacopa Cognition Randomized TrialFindings are expected to inform preventive and personalized strategies, contributing to evidence-based applications of Bacopa monnieri in healthy aging.2Pradeep HLNR (2026)Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
Bacopa Cognition Randomized TrialBackground Aging is an irreversible process shaped by genetic and environmental factors.2Pradeep HLNR (2026)Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
Bacopa Cognition Randomized TrialProgrammed theories propose aging follows a biological clock, while error theories attribute it to environmental damage.2Pradeep HLNR (2026)Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
Bacopa Cognition Randomized TrialBacopa consumption is known to enhance cognitive performance in healthy individuals and is associated with alterations in pathways related to branched-chain and aromatic amino acid biosynthesis.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Randomized TrialThe cohort predominantly comprises men (53/60, 88.3%), individuals with at least a high school education (47/60, 78.3%), and participants at elevated risk for cognitive decline.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Randomized TrialBackground Amnestic mild cognitive impairment (aMCI) represents a transitional stage between normal aging and Alzheimer disease (AD), where early intervention is critical for preserving cognition and delaying or preventing progression to dementia.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Randomized TrialDue to the limited availability of curative pharmacological treatments, there is growing interest in traditional and indigenous medicinal interventions, such as Bacopa monnieri (Linn.) or Brahmi, a widely used Ayurvedic nootropic herb.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Randomized Trial
claimDiscussion This trial will provide evidence on BMFD's potential to preserve telomere length, support cognitive functions, and slow aging processes.
evidence level2
citationPradeep HLNR (2026)
sourceEffects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
topicBacopa Cognition Randomized Trial
claimFindings are expected to inform preventive and personalized strategies, contributing to evidence-based applications of Bacopa monnieri in healthy aging.
evidence level2
citationPradeep HLNR (2026)
sourceEffects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
topicBacopa Cognition Randomized Trial
claimBackground Aging is an irreversible process shaped by genetic and environmental factors.
evidence level2
citationPradeep HLNR (2026)
sourceEffects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
topicBacopa Cognition Randomized Trial
claimProgrammed theories propose aging follows a biological clock, while error theories attribute it to environmental damage.
evidence level2
citationPradeep HLNR (2026)
sourceEffects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
topicBacopa Cognition Randomized Trial
claimBacopa consumption is known to enhance cognitive performance in healthy individuals and is associated with alterations in pathways related to branched-chain and aromatic amino acid biosynthesis.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Randomized Trial
claimThe cohort predominantly comprises men (53/60, 88.3%), individuals with at least a high school education (47/60, 78.3%), and participants at elevated risk for cognitive decline.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Randomized Trial
claimBackground Amnestic mild cognitive impairment (aMCI) represents a transitional stage between normal aging and Alzheimer disease (AD), where early intervention is critical for preserving cognition and delaying or preventing progression to dementia.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Randomized Trial
claimDue to the limited availability of curative pharmacological treatments, there is growing interest in traditional and indigenous medicinal interventions, such as Bacopa monnieri (Linn.) or Brahmi, a widely used Ayurvedic nootropic herb.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.

Learn next

Related evidence and supplement guides

GuideGrape Seed Cognition Randomized Trial: What the Evidence SaysGrape Seed Cognition Randomized Trial has 2 source documents in the current Migaku evidence data...GuideZeaxanthin Cognition Randomized Trial: What the Evidence SaysZeaxanthin Cognition Randomized Trial has 2 source documents in the current Migaku evidence data...GuideMethylfolate Cognition Randomized Trial: What the Evidence SaysMethylfolate Cognition Randomized Trial has 2 source documents in the current Migaku evidence da...GuideLion's Mane Cognition Randomized Trial: What the Evidence SaysLion's Mane Cognition Randomized Trial has 3 source documents in the current Migaku evidence dat...RankingBest Nootropics for Focus & Attention: 2026 Clinical Evidence ReviewWe separate the clinical evidence from the marketing hype, ranking the most effective brain supp...RankingBest Supplements for Anxiety: Evidence-Based Rankings 2026Anxiety supplements with genuine clinical evidence include ashwagandha (strongest for chronic an...RankingBest Nootropics for Focus & Cognition: 2026 Clinical RankingsAn examination of cognitive enhancers designed to increase neurotransmitter activity, improve sy...AnswerDoes Grape Seed Cognition Randomized Trial work?Grape Seed Cognition Randomized Trial has evidence relevant to strength of evidence and what the...

Source documents

  1. Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol.
  2. Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.